{"@id":"https://bioecon.ru/technology/oral-t-cell-immunotherapy-via-attenuated-bacteria/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://bioecon.ru/technology/oral-t-cell-immunotherapy-via-attenuated-bacteria/","json":"https://bioecon.ru/api/v1/technology/oral-t-cell-immunotherapy-via-attenuated-bacteria/index.json"},"id":"oral-t-cell-immunotherapy-via-attenuated-bacteria","industries":["pharma","biomanufacturing"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/becton-dickinson/","https://bioecon.ru/companies/wildtype/","https://bioecon.ru/companies/enzymicals-ag/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/simple-planet/","https://bioecon.ru/companies/cellmeat/","https://bioecon.ru/companies/integriculture/"]},"maturity":7,"name":"Пероральная Т-клеточная иммунотерапия аттенуированными бактериями","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Необратимая аттенуация бактерий"},{"n":2,"title":"Загрузка эукариотических плазмид"},{"n":3,"title":"Таргетирование пейеровых бляшек"},{"n":4,"title":"Запуск цитотоксического иммунитета"}],"summary":"Живые генетически ослабленные бактерии Salmonella, несущие эукариотические плазмиды и доставляемые в кишечнорастворимых капсулах для активации дендритных клеток пейеровых бляшек против опухоли.","url":"/technology/oral-t-cell-immunotherapy-via-attenuated-bacteria/","verified":"2026-11-22"}